BI
JSPRW icon

Bulldog Investors’s Japer Therapeutics Warrants JSPRW Stock Holding History

Bulldog Investors’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-47,887
Closed -$71K – 292
2021
Q3 		$71K Sell
47,887
-43,846
-48% -$46.9K 0.02% 207
2021
Q2 		$105K Hold
91,733
– – 0.03% 200
2021
Q1 		$75K Buy
91,733
+1,625
+2% +$2.38K 0.02% 189
2020
Q4 		$131K Sell
90,108
-2,100
-2% -$2.63K 0.05% 129
2020
Q3 		$103K Sell
92,208
-1,750
-2% -$1.77K 0.03% 115
2020
Q2 		$94K Buy
+93,958
New +$58.5K 0.04% 106

Other funds holding JSPRW

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
ICMH
Integrity Capital Management (HK) Central, Hong Kong $64K AUM
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Bulldog Investors's JSPRW Position: Q4 2021 in Review

Bulldog Investors sold out of Japer Therapeutics Warrants (JSPRW) in Q4 2021, closing a stake of 47,887 shares — an estimated $71K sold.

Bulldog Investors first reported a position in JSPRW in Q2 2020 and held it in 6 quarters. The position peaked at $131K in Q4 2020. 15 funds tracked by Wall St. Rank hold JSPRW as of Q4 2021.

  • Bulldog Investors reported no remaining Japer Therapeutics Warrants position as of Q4 2021 after selling out during the quarter.
  • Bulldog Investors sold 47,887 Japer Therapeutics Warrants shares in Q4 2021, an estimated $71K.
  • Bulldog Investors first reported a position in Japer Therapeutics Warrants in Q2 2020 and held it in 6 quarters.
  • Bulldog Investors's Japer Therapeutics Warrants position peaked at $131K in Q4 2020.
  • 15 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q4 2021.

Based on Bulldog Investors's 13F filing for Q4 2021, filed 11 Feb 2022.